OA08907A - Process for polymorphic crystalline form conversion. - Google Patents

Process for polymorphic crystalline form conversion.

Info

Publication number
OA08907A
OA08907A OA59414A OA59414A OA08907A OA 08907 A OA08907 A OA 08907A OA 59414 A OA59414 A OA 59414A OA 59414 A OA59414 A OA 59414A OA 08907 A OA08907 A OA 08907A
Authority
OA
OAPI
Prior art keywords
crystalline form
polymorphic crystalline
form conversion
polymorphic
conversion
Prior art date
Application number
OA59414A
Other languages
English (en)
Inventor
Robert J Behme
Terry T Kensler
Douglas G Mikolasek
Robert James Behme
Terry Tim Kensler
Douglas Gene Mikolasek
Original Assignee
Bristol Myers Squibb Co
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Bristol Myers Co filed Critical Bristol Myers Squibb Co
Publication of OA08907A publication Critical patent/OA08907A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Gears, Cams (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Arrangement Or Mounting Of Propulsion Units For Vehicles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Body Structure For Vehicles (AREA)
OA59414A 1987-08-28 1988-08-26 Process for polymorphic crystalline form conversion. OA08907A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/090,302 US4810789A (en) 1987-08-28 1987-08-28 Process for buspirone hydrochloride polymorphic crystalline form conversion

Publications (1)

Publication Number Publication Date
OA08907A true OA08907A (en) 1989-10-31

Family

ID=22222189

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59414A OA08907A (en) 1987-08-28 1988-08-26 Process for polymorphic crystalline form conversion.

Country Status (23)

Country Link
US (1) US4810789A (no)
EP (1) EP0304940B1 (no)
JP (1) JP2702519B2 (no)
KR (1) KR970011294B1 (no)
AT (1) ATE113044T1 (no)
AU (1) AU618746B2 (no)
CY (1) CY1839A (no)
DE (1) DE3851865T2 (no)
DK (1) DK478688A (no)
ES (1) ES2060632T3 (no)
FI (1) FI91066C (no)
HK (1) HK71495A (no)
HU (1) HU199831B (no)
IE (1) IE65988B1 (no)
IL (1) IL87292A (no)
MY (1) MY100863A (no)
NO (1) NO169284C (no)
NZ (1) NZ225895A (no)
OA (1) OA08907A (no)
PT (1) PT88355B (no)
SU (1) SU1731056A3 (no)
YU (1) YU46961B (no)
ZA (1) ZA885867B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
HU217129B (hu) * 1993-07-16 1999-11-29 EGIS Gyógyszergyár Rt. Eljárás nagy tisztaságú buspiron gyógyászati hatóanyag előállítására
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
KR100322018B1 (ko) * 1999-01-23 2002-02-04 윤종용 음성대역 잡음 보상장치
US6465255B1 (en) * 1999-01-29 2002-10-15 The Regents Of The University Of California Method for identifying and probing phase transitions in materials
DE60216641T2 (de) * 2002-04-19 2007-09-27 Faes Farma S.A. Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4351939A (en) * 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone

Also Published As

Publication number Publication date
ATE113044T1 (de) 1994-11-15
ES2060632T3 (es) 1994-12-01
PT88355B (pt) 1995-12-29
NO883806L (no) 1989-03-01
FI883960A0 (fi) 1988-08-26
NO169284B (no) 1992-02-24
FI883960A (fi) 1989-03-01
FI91066C (fi) 1994-05-10
HUT47563A (en) 1989-03-28
IL87292A (en) 1992-07-15
SU1731056A3 (ru) 1992-04-30
DK478688A (da) 1989-03-01
YU46961B (sh) 1994-09-09
AU2048088A (en) 1989-03-02
PT88355A (pt) 1989-06-30
US4810789A (en) 1989-03-07
NO883806D0 (no) 1988-08-25
FI91066B (fi) 1994-01-31
KR970011294B1 (ko) 1997-07-09
NZ225895A (en) 1991-04-26
DK478688D0 (da) 1988-08-26
DE3851865T2 (de) 1995-02-23
JP2702519B2 (ja) 1998-01-21
JPS6471872A (en) 1989-03-16
YU160488A (en) 1990-04-30
AU618746B2 (en) 1992-01-09
HK71495A (en) 1995-05-19
HU199831B (en) 1990-03-28
ZA885867B (en) 1989-05-30
MY100863A (en) 1991-03-15
KR890003739A (ko) 1989-04-17
IE65988B1 (en) 1995-11-29
IE882362L (en) 1989-02-28
EP0304940B1 (en) 1994-10-19
IL87292A0 (en) 1989-01-31
EP0304940A1 (en) 1989-03-01
CY1839A (en) 1995-12-01
NO169284C (no) 1992-06-03
DE3851865D1 (de) 1994-11-24

Similar Documents

Publication Publication Date Title
YU44797B (en) Process for producing substituted pyridinsulphonamde compound
HUT45534A (en) Process for producing new 23-oxo- and 23-imino-derivatives of ll-f 28249 compounds
IL95303A0 (en) Process for the preparation of 23-(c1-c6alkyloxime)-ll-f28249 compounds
IL101051A0 (en) Preparation of substituted tetrahydropyridines
ZA885867B (en) Process for polymorphic crystalline form conversion
HUT43992A (en) Process for production of crystalline metall-gluconates
HUT48571A (en) Process for production of substituated 3,5-dichlor-2,4-difluor-benzol
EP0448544A3 (en) Process for preparation of fluoromethyl-substituted piperidine carbodithioates
FR2592873A1 (fr) Nouveau derive monophosphazene, procede d'obtention et application
IL97584A0 (en) Process for preparation of fluoromethyl-substituted piperidine carbodithioates
HUT44039A (en) Process for production of 9/11/ dihydro-androstanes
HUT48280A (en) Process for production of starch-2,3,/dihydroxi-prophile/-ether
PL265928A2 (en) Method of obtaining novel compound of 2,2,3,4,4-pentamethyl-1,3-oxazolydine
PL248249A2 (en) Process for preparing novel ethyl ester of 10-carboxymethyl-1,2,3,4-tetrahydroacridone
PL248251A2 (en) Process for preparing novel ethyl ester of 2,7-dibromo-10-carboxymethyl-acridone
HUT46302A (en) Process for producing 6,9-phenylamino-analogues of prostacyclin
HUT44473A (en) Process for production of 1,2-dietoxi-benzol
YU250089A (en) Process for conversion of polymorpheous crystalline shape